Atara Biotherapeutics Inc stock is traded at $6.50, with a volume of 71,653. It is up +1.56% in the last 24 hours and down -29.19% over the past month. Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Previous Close:
$6.40
Open:
$6.40
24h Volume:
71,653
Relative Volume:
2.72
Market Cap:
$66.22M
Revenue:
$23.14M
Net Income/Loss:
-$9.47M
P/E Ratio:
-
EPS:
-$0.8827
Net Cash Flow:
-$25.88M
1W Performance:
-19.75%
1M Performance:
-29.19%
6M Performance:
-32.15%
1Y Performance:
-50.38%
1-Day Range:
$5.98$7.02
1-Week Range:
$5.98$8.41
52-Week Range:
$3.92$19.15
Atara Biotherapeutics Inc Stock (ATRA) Company Profile
Name
Atara Biotherapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
805-623-4211Address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS